Back
New York Times 10K Form
Buy
56
NYT
New York Times
Last Price:
53.21
Seasonality Move:
8.17%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | NYT/New York Times Quarterly |
| 2024-02-20 | 10K | NYT/New York Times Annual |
| 2023-11-08 | 10Q | NYT/New York Times Quarterly |
| 2023-08-08 | 10Q | NYT/New York Times Quarterly |
| 2023-05-10 | 10Q | NYT/New York Times Quarterly |
| 2023-02-28 | 10K | NYT/New York Times Annual |
Receive NYT News And Ratings
See the #1 stock for the next 7 days that we like better than NYT
NYT Financial Statistics
Sales & Book Value
| Annual Sales: | $2.43B |
|---|---|
| Cash Flow: | $118.45M |
| Price / Cash Flow: | 23.66 |
| Annual Sales: | $11.29 |
| Price / Book: | 4.65 |
Profitability
| EPS (TTM): | 1.69000 |
|---|---|
| Net Income (TTM): | $279.98M |
| Gross Margin: | $1.18B |
| Return on Equity: | 15.87% |
| Return on Assets: | 10.51% |
New York Times Earnings Forecast
Key New York Times Financial Ratios
- The Gross Profit Margin over the past 40 years for NYT is 48.52%.
- The Selling, General & Administrative Expenses for NYT have been equal to 23.55% of Gross Profit Margin.
- The Research & Development expenses have been 9.43% of Revenue.
- The Interest Expense is 0.44% of Operating Income.
- The Net Earning history of NYT is 9.58% of Total Revenues.
- Per Share Earnings over the last 40 years have been positive in 22 years.
New York Times Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Media |
| Sector: | Communication Services |
| Current Symbol: | NYT |
| CUSIP: | 650111 |
| Website: | nytco.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 1.35 |
| Quick Ratio: | 1.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 37.51 |
|---|---|
| Forward P/E Ratio: | 25.35 |
NYT Technical Analysis vs Fundamental Analysis
Buy
56
New York Times (NYT)
is a Buy
Is New York Times a Buy or a Sell?
-
New York Times stock is rated a Buy
The current New York Times [NYT] share price is $52.01. The Score for NYT is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.